Document is current
Any future updates will be listed below
-
Authors
Kanwal, Sajida
To, Shaina Vivienne
Uijen, Rienke
Roverts, Rona
van Cranenbroek, Bram
van Opzeeland, Fred J.
Joosten, Ben
van den Berg van Saparoea, Bart
van der Gaast-de Jongh, Christa E.
van Rijssen, Esther
Luirink, Joen
Diavatopoulos, Dimitri A.
van Beek, Lucille F.
de Jonge, Marien I.
-
Funding
Funding for this research was provided by:
Horizon 2020 MSCA fellowship
- License Information
-
More Information
Article History
Received: 27 November 2025
Accepted: 11 March 2026
First Online: 30 March 2026
Competing interests
: Conflicts of interest are in Abera Bioscience AB that aims to exploit the presented OMV technology and has patented this vaccine platform18. The vaccine candidate and the immunization studies conducted in this study are based on information available in this patent application. However, the insights gained through this manuscript are not part of the patent.
